Citation Impact
Citing Papers
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
2011 Standout
Extended Virulence Genotypes ofEscherichia coliStrains from Patients with Urosepsis in Relation to Phylogeny and Host Compromise
2000 Standout
Immunomodulation in the critically ill
2009
Automation of measurements and data evaluation in biomolecular NMR screening
2001
Transient expression of IL-1β induces acute lung injury and chronic repair leading to pulmonary fibrosis
2001 Standout
Acute kidney injury
2012 Standout
Biological activities and pharmaceutical applications of polysaccharide from natural resources: A review
2017 Standout
MYC on the Path to Cancer
2012 Standout
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
2004 Standout
Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis
2013 Standout
Pro-resolving lipid mediators are leads for resolution physiology
2014 StandoutNature
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
2019 Standout
Understanding the Inflammatory Cytokine Response in Pneumonia and Sepsis
2007
Marine natural products
1990 Standout
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Animal models of sepsis and sepsis-induced kidney injury
2009
Antithrombin III in patients with severe sepsis
1998
Pathophysiology of Sepsis
2007
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Cancer Epigenetics: From Mechanism to Therapy
2012 Standout
The Next Generation of Sepsis Clinical Trial Designs
2014
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
2013 Standout
Severe Sepsis and Septic Shock
2013 Standout
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Sepsis and septic shock
2018 Standout
Protection from experimental ventilator-induced acute lung injury by IL-1 receptor blockade
2007
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis
2002
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
High impact technologies for natural products screening
2007
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
2020 Standout
Cardiac Fibroblasts Contribute to Myocardial Dysfunction in Mice with Sepsis: The Role of NLRP3 Inflammasome Activation
2014
Clinical Practice Guidelines for Hospital‐Acquired Pneumonia and Ventilator‐Associated Pneumonia in Adults
2007
The Pathophysiology and Treatment of Sepsis
2003 Standout
Hidradenitis suppurativa
2020 Standout
Mechanisms and Functions of Inflammasomes
2014 Standout
Procalcitonin (PCT) is useful in predicting the bacterial origin of an acute circulatory failure in critically ill patients
2000
COVID-19: consider cytokine storm syndromes and immunosuppression
2020 Standout
Protective and pathogenic functions of macrophage subsets
2011 Standout
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
2012
Disseminated Intravascular Coagulation
1999 Standout
The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1β
2006
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
The coagulopathy of acute sepsis
2015
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome
2015
Monocyte deactivation-rationale for a new therapeutic strategy in sepsis
1996
Cancer-related inflammation
2008 StandoutNature
The inflammatory reflex
2002 StandoutNature
Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine
2014 Standout
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
2009 Standout
Progress in the Discovery of Small-Molecule Inhibitors of Bromodomain–Histone Interactions
2011
Nmr in drug discovery
2002 StandoutNobel
Autoinflammation: The prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses
2009
The Multifaceted Effects of Polysaccharides Isolated from Dendrobium huoshanense on Immune Functions with the Induction of Interleukin-1 Receptor Antagonist (IL-1ra) in Monocytes
2014
An Official American Thoracic Society Workshop Report: Features and Measurements of Experimental Acute Lung Injury in Animals
2011 Standout
Assessment of Clinical Criteria for Sepsis
2016 Standout
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
2016 Standout
Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis.
1995
The NLRP3 inflammasome in health and disease: the good, the bad and the ugly
2011
Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses.
1995
Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women
2014 Standout
The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
2019 Standout
Overview of the IL ‐1 family in innate inflammation and acquired immunity
2017
Hemolytically Active (Acylated) Alpha-Hemolysin Elicits Interleukin-1β (IL-1β) but Augments the Lethality ofEscherichia coliby an IL-1- and Tumor Necrosis Factor-Independent Mechanism
1998
Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice.
1996
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
Immunological and Inflammatory Functions of the Interleukin-1 Family
2009 Standout
Interleukin 10 reduces mortality from severe peritonitis in mice
1995
Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation
2002
Cytokine Storm
2020 Standout
Targeting Interleukin-1 in Heart Disease
2013
Computational Evolution of Threonine-Rich β-Hairpin Peptides Mimicking Specificity and Affinity of Antibodies
2019 StandoutNobel
Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1
2007 StandoutNobel
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
2011 Standout
Interleukin-1 blockade for the treatment of pericarditis
2017
The Pathogenesis of Sepsis
2011
Targeted adenovirus-induced expression of IL-10 decreases thymic apoptosis and improves survival in murine sepsis
2001
Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response
2004 Standout
Developing a New Definition and Assessing New Clinical Criteria for Septic Shock
2016 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Sepsis: Multiple Abnormalities, Heterogeneous Responses, and Evolving Understanding
2013
Integrating mechanisms of pulmonary fibrosis
2011 Standout
Works of Shapiro Mj being referenced
Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.
1994
High resolution NMR for screening ligand/protein binding.
1999